Factor XIII deficiency

Common Name(s)

Factor XIII deficiency

Factor XIII deficiency is an extremely rare inherited blood disorder characterized by abnormal blood clotting that may result in abnormal bleeding. Signs and symptoms occur as the result of a deficiency in the blood clotting factor 13, which is responsible for stabilizing the formation of a blood clot. In affected individuals, the blood fails to clot appropriately, resulting in poor wound healing. Blood may seep into surrounding soft tissues, resulting in local pain and swelling. Internal bleeding may occur; about 25 percent of affected individuals experience bleeding in the brain. FXIII deficiency is usually caused by mutations in the F13A1 gene, but mutations have also been found in the F13B gene. It is usually inherited in an autosomal recessive fashion. Acquired forms have also been reported in association with liver failure, inflammatory bowel disease, and myeloid leukemia.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Factor XIII deficiency" for support, advocacy or research.

Caring Voice Coalition,Inc,

Caring Voice Coalition empowers patients who live with a life threatening chronic disease through comprehensive outreach programs and services aimed at financial, emotional and educational support. With a steadfast dedication to the organization’s set of core values, our knowledgeable, caring staff maintains our solid reputation as a dependable, responsive organization with a unique, holistic approach to improving the lives of our patients.

Last Updated: 29 Apr 2014

View Details
Logo
The Haemophilia Society

To ensure that people affected by bleeding disorders have the freedom to make choices and seize opportunities To enable people affected by bleeding disorders to better understand and manage their condition or situation. To enable people affected by bleeding disorders to participate in decision making and service delivery. To influence policy and improve services to people with bleeding disorders.

Last Updated: 3 Apr 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Factor XIII deficiency" for support, advocacy or research.

Caring Voice Coalition,Inc,

Caring Voice Coalition empowers patients who live with a life threatening chronic disease through comprehensive outreach programs and services aimed at financial, emotional and educational support. With a steadfast dedication to the organization’s set of core values, our knowledgeable, caring staff maintains our solid reputation as a dependable, responsive organization with a unique, holistic approach to improving the lives of our patients.

http://www.caringvoice.org

Last Updated: 29 Apr 2014

View Details
Logo
The Haemophilia Society

To ensure that people affected by bleeding disorders have the freedom to make choices and seize opportunities To enable people affected by bleeding disorders to better understand and manage their condition or situation. To enable people affected by bleeding disorders to participate in decision making and service delivery. To influence policy and improve services to people with bleeding disorders.

http://www.haemophilia.org.uk/

Last Updated: 3 Apr 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Factor XIII deficiency" returned 28 free, full-text research articles on human participants. First 3 results:

Tocilizumab induced acquired factor XIII deficiency in patients with rheumatoid arthritis.
 

Author(s): Sho Mokuda, Yosuke Murata, Naoya Sawada, Kenichiro Matoba, Akihiro Yamada, Makoto Onishi, Yasuaki Okuda, Kazuo Jouyama, Eiji Sugiyama, Kiyoshi Takasugi

Journal:

 

Factor XIII is one of the twelve coagulation factors and also known as a fibrin-stabilizing factor. In 2012, we encountered a male RA patient with hemorrhagic factor XIII deficiency who had been treated with tocilizumab for two years. There are few reports regarding the relationship ...

Last Updated: 12 Aug 2013

Go To URL
Hyperfibrinolysis and acquired factor XIII deficiency in newly diagnosed pediatric malignancies.
 

Author(s): Verena Wiegering, Oliver Andres, Paul G Schlegel, Frank Deinlein, Matthias Eyrich, Alexander Sturm

Journal: Haematologica. 2013 Aug;98(8):e90-1.

 

Last Updated: 1 Aug 2013

Go To URL
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency.
 

Author(s): Aida Inbal, Johannes Oldenburg, Manuel Carcao, Anders Rosholm, Ramin Tehranchi, Diane Nugent

Journal: Blood. 2012 May;119(22):5111-7.

 

Congenital factor XIII (FXIII) deficiency is a rare, autosomal-recessive disorder, with most patients having an A-subunit (FXIII-A) deficiency. Patients experience life-threatening bleeds, impaired wound healing, and spontaneous abortions. In many countries, only plasma or cryoprecipitate ...

Last Updated: 1 Jun 2012

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Factor XIII deficiency" returned 3 free, full-text review articles on human participants. First 3 results:

Factor XIII deficiency in Henoch-Schönlein purpura - report on two cases and literature review.
 

Author(s): Anna Hogendorf, Wojciech Młynarski

Journal: Dev Period Med. ;18(3):318-22.

 

Factor XIII (FXIII) deficiency is a rare, inherited or acquired coagulation disorder that potentially precipitates fatal haemorrhage. We report two consecutive pediatric patients with Henoch-Schönlein purpura (HSP) and symptomatic decrease in FXIII. The possible FXIII deficiency ...

Last Updated: 3 Sep 2014

Go To URL
Congenital factor XIII deficiency in Switzerland: from the worldwide first case in 1960 to its molecular characterisation in 2005.
 

Author(s): V Schroeder, D Durrer, E Meili, G Schubiger, H P Kohler

Journal: Swiss Med Wkly. 2007 May;137(19-20):272-8.

 

Coagulation factor XIII (FXIII) has a major role in the final stage of blood coagulation, is important for wound healing and maintaining pregnancy. Severe congenital FXIII deficiency is a rare disorder with 1 patient in 1-3 million. Untreated, it causes bleeding events, with intracranial ...

Last Updated: 27 Jun 2007

Go To URL
Acquired factor XIII deficiency due to an inhibitor: a case report and review of the literature.
 

Author(s): A V M Nijenhuis, L van Bergeijk, P C Huijgens, S Zweegman

Journal:

 

Last Updated: 11 May 2004

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Clinical Trial of Factor XIII Concentrate
 

Status: Recruiting

Condition Summary: Hemophilia; Factor XIII Deficiency

 

Last Updated: 17 Mar 2008

Go to URL
Factor XIII and Pulmonary Embolism in Neurosurgical Patients
 

Status: Recruiting

Condition Summary: Brain Tumor; Vascular Lesion; Factor XIII Deficiency; Pulmonary Embolism

 

Last Updated: 19 Apr 2010

Go to URL